AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NEW YORK, April 7 (UPI) -- A new experimental vaccine can reduce the risk of cervical cancer by 90 percent, a study says.
The vaccine, made by Merck and called Gardasil, made its mark in a survey of 552 women, findings of which were published in the British medical journal Lancet Oncology.
The study is another sign the first vaccine that could prevent most of the world's cervical-cancer cases is just around the corner, the Wall Street Journal said Thursday.
Merck…